Viewing Study NCT04850495


Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2026-05-17 @ 9:59 PM
Study NCT ID: NCT04850495
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2021-04-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
Sponsor: Yazeed Sawalha
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-Cell Lymphoma View
None Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma View
None Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma View
Keywords: